@ARTICLE{
author={Robak Tadeusz,Windyga Jerzy,Trelinski Jacek,Prondzinski Mario von Depka,Giagounidis Aristoteles,Doyen Chantal,Janssens Ann,Teresa Alvarez-Roman Maria,Jarque Isidro,Loscertales Javier,Perez-Rus Gloria,Hellmann Andrzej,Jedrzejczak Wieslaw Wiktor,Kuliczkowski Kazimierz,Golubovic Lana M,Celeketic Dusica C,Cucuianu Andrei,Gheorghita Emanuil,Lazaroiu Mihaela,Shpilberg Ofer,Attias Dina,Karyagina Elena,Svetlana Kalinina,Vilchevska Kateryna,Cooper Nichola,Talks Kate,Prabhu Mukhyaprana,Sripada Prasad,Bharadwaj TPR,Naested Henrik,Skartved Niels JO,Frandsen Torben P,Flensburg Mimi F,S-Andersen Peter,Petersen Jorgen B},
year={2012},
title={Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia},
journal={BLOOD},
volume={120},
number={18},
pages={3670-3676},
document_type={Article},
}